Andrea Santucci
Overview
Explore the profile of Andrea Santucci including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
221
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Santucci A, Almeida N, Kara-Junior N
Arq Bras Oftalmol
. 2025 Feb;
88(3):e20240389.
PMID: 40008771
No abstract available.
2.
Ciliberti G, Fortuni F, Santucci A, Timi A, Barnoffi E, Coiro S, et al.
Int J Cardiol
. 2025 Feb;
424:133039.
PMID: 39914630
Background: Myocardial infarction without obstructive coronary artery disease (MINOCA) is a challenging condition which requires appropriate management and therapy. Although specific guidelines and recommendations for this condition have been introduced,...
3.
Angeli F, Verdecchia P, Coiro S, Santucci A, Notaristefano F, Bartolini C, et al.
G Ital Cardiol (Rome)
. 2024 Mar;
25(4):262-269.
PMID: 38526362
Superiority trials are designed to test the hypothesis that a given diagnostic or therapeutic strategy is better than (i.e. "superior to") placebo or an active control. Conversely, non-inferiority trials test...
4.
Verdecchia P, Cavallini C, Sclafani R, Santucci A, Notaristefano F, Zingarini G, et al.
Eur J Intern Med
. 2023 Aug;
117:66-77.
PMID: 37544846
Catheter-based renal artery denervation (RAD) is entering a new era. After the disappointing results of SYMPLICITY-HTN 3 trial in year 2014, several technical and methodological advancements led to execution of...
5.
Angeli F, Reboldi G, Solano F, Prosciutto A, Paolini A, Zappa M, et al.
Diagnostics (Basel)
. 2023 May;
13(9).
PMID: 37174992
Several outcome-based prospective investigations have provided solid data which support the prognostic value of 24 h ambulatory blood pressure over and beyond cardiovascular traditional risk factors. Average 24 h, daytime,...
6.
Verdecchia P, Murdolo G, Coiro S, Santucci A, Notaristefano F, Angeli F, et al.
Eur Heart J Suppl
. 2023 Apr;
25(Suppl B):B171-B176.
PMID: 37091638
Metformin is a frequently used anti-diabetic drug. In addition to the well-known modulating properties on glyco-metabolic control, metformin reduces cardiovascular (CV) risk partly independently of its anti-hyperglycaemic effect. The use...
7.
Santucci A, Jacoangeli F, Cavallini S, DAmmando M, De Angelis F, Cavallini C
Eur Heart J Suppl
. 2022 Nov;
24(Suppl I):I61-I67.
PMID: 36380808
The myocardial bridge (MB) is a common anomaly of the coronary tree, very often clinically silent. The artery typically involved is the left anterior descending in its proximal and/or middle...
8.
Verdecchia P, Coiro S, Notaristefano F, Santucci A, De Angelis F, DAmmando M, et al.
Eur Heart J Suppl
. 2022 Nov;
24(Suppl I):I190-I196.
PMID: 36380799
The proliferation of good quality observational studies on the potential adverse effects of COVID-19 vaccination has greatly increased our knowledge on myocarditis and pericarditis, and also, more recently, on arterial...
9.
Santucci A, Cavallini C
G Ital Cardiol (Rome)
. 2022 Jun;
23(7):523-532.
PMID: 35771018
Type 2 myocardial infarction is the ischemic necrosis of cardiomyocytes due to oxygen supply/demand imbalance. The most common causes are surgery, sepsis, arrhythmias, hypo/hypertension. Patients with type 2 myocardial infarction,...
10.
Ciccirillo F, Abrignani M, Grosseto D, Amico A, Cocozza S, Gabriele M, et al.
G Ital Cardiol (Rome)
. 2022 Jun;
23(6):444-453.
PMID: 35674035
Cocaine abuse is widely increasing, especially in younger individuals. Cocaine is a major cause of chest pain and acute coronary syndrome and is the leading cause for drug abuse-related visits...